The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALPHATEC HOLDINGS INC | COM NEW | 02081G201 | 1,370 | 426,855 | SH | SOLE | 426,855 | 0 | 0 | ||
| AMERISOURCEBERGEN CORP | COM | 03073E105 | 8,366 | 107,000 | SH | SOLE | 107,000 | 0 | 0 | ||
| ANIKA THERAPEUTICS INC | COM | 035255108 | 8,615 | 175,967 | SH | SOLE | 175,967 | 0 | 0 | ||
| ANTHEM INC | COM | 036752103 | 8,094 | 56,300 | SH | SOLE | 56,300 | 0 | 0 | ||
| CARDINAL HEALTH INC | COM | 14149Y108 | 8,478 | 117,800 | SH | SOLE | 117,800 | 0 | 0 | ||
| CHARLES RIV LABS INTL INC | COM | 159864107 | 8,466 | 111,112 | SH | SOLE | 111,112 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 8,092 | 113,000 | SH | SOLE | 113,000 | 0 | 0 | ||
| GNC HLDGS INC | COM CL A | 36191G107 | 4,669 | 422,955 | SH | SOLE | 422,955 | 0 | 0 | ||
| IMMUCELL CORP | COM PAR $0.10 | 452525306 | 1,002 | 168,323 | SH | SOLE | 168,323 | 0 | 0 | ||
| MCKESSON CORP | COM | 58155Q103 | 8,006 | 57,000 | SH | SOLE | 57,000 | 0 | 0 | ||
| MERCK & CO INC | COM | 58933Y105 | 8,012 | 136,100 | SH | SOLE | 136,100 | 0 | 0 | ||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 13,591 | 538,241 | SH | SOLE | 538,241 | 0 | 0 | ||
| SYNERON MEDICAL LTD | ORD SHS | M87245102 | 5,931 | 706,107 | SH | SOLE | 706,107 | 0 | 0 | ||
| TARO PHARMACEUTICAL INDS LTD | SHS | M8737E108 | 8,306 | 78,905 | SH | SOLE | 78,905 | 0 | 0 | ||
| TRIPLE-S MGMT CORP | CL B | 896749108 | 7,538 | 364,156 | SH | SOLE | 364,156 | 0 | 0 | ||